Verona Pharma plc (VRP.L) (LON:VRP) Stock Price Passes Above 200 Day Moving Average of $46.00

Verona Pharma plc (VRP.L) (LON:VRPGet Rating) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 46 ($0.58) and traded as high as GBX 56 ($0.70). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.69), with a volume of 70,791 shares changing hands.

The firm has a market cap of £228.00 million and a price-to-earnings ratio of -1.68. The company’s 50-day moving average price is GBX 55 and its 200-day moving average price is GBX 46.13. The company has a quick ratio of 2.47, a current ratio of 2.99 and a debt-to-equity ratio of 6.85.

Verona Pharma plc (VRP.L) Company Profile (LON:VRP)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.

Read More

Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with's FREE daily email newsletter.